Need Help? Call 1­-866-­796-­7386
« back to stock screener

  CGIX stock: Cancer Genetics Inc

Current Rating
Sell

Previous Rating

Sell
Our Strong Buys
double the S&P500!
Learn more.
Company Statistics
Price
$3.82
Market Cap
12.6M
Sector
Health Care
Div. Growth
-
P/E
-
P/B
2.55
P/S
1.9
Dividend %
-
P/CF
6.7
P/FCF
-
Op. Cash Flow
-5.7K
FCF
-
Op. Margin
-98.20%
Net Margin
-17.50%
ROE
-18.20%
ROI
-59.00%
ROA
-7.70%
EPS Growth
97.20%
Current Ratio
1.0
Debt/Equity
1.40%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Vycor Medical Inc (VYCO) $0.18 - - 4.9M Strong Buy
Teva Pharmaceutical Industries (TEVA) $8.72 - - 10.43B Strong Buy
Capital Senior Living Corporat (CSU) $0.66 - - 21.7M Strong Buy
Bioanalytical Systems, Inc. (BASI) $4.86 - - 51.6M Strong Buy
Amneal Pharmaceuticals Inc (AMRX) $3.96 - - 1.23B Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More